In vitro evaluation of ap53-expressing adenovirus as an anti-cancer drug
Open Access
- 29 July 1996
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 67 (3), 386-392
- https://doi.org/10.1002/(sici)1097-0215(19960729)67:3<386::aid-ijc13>3.0.co;2-6
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- A Controlled Study of Adenoviral-Vector–Mediated Gene Transfer in the Nasal Epithelium of Patients with Cystic FibrosisNew England Journal of Medicine, 1995
- A p53-Dependent Mouse Spindle CheckpointScience, 1995
- Cytostatic Gene Therapy for Vascular Proliferative Disorders with a Constitutively Active form of the Retinoblastoma Gene ProductScience, 1995
- Cell Cycle Control and CancerScience, 1994
- Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo.Proceedings of the National Academy of Sciences, 1994
- Chapter 2 Assays of Cell Viability: Discrimination of Cells Dying by ApoptosisMethods in Cell Biology, 1994
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993
- Gene therapy: adenovirus vectorsCurrent Opinion in Genetics & Development, 1993
- Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumoursNature, 1992
- P‐glycoprotein expression and schedule dependence of adriamycin cytotoxicity in human colon carcinoma cell linesInternational Journal of Cancer, 1991